For the quarter ending 2026-03-29, QDEL had -$29,400K decrease in cash & cash equivalents over the period. -$67,000K in free cash flow.
| Cash Flow | 2026-03-29 | 2025-12-28 | 2025-09-28 | 2025-06-29 |
|---|---|---|---|---|
| Asset impairment charge | - | 0 | 9,700 | 0 |
| Goodwill impairment charge | - | 0 | 700,700 | 0 |
| Net loss | -91,800 | -130,700 | -733,000 | -268,100 |
| Payment of accreted interest on contingent and deferred consideration | - | 0 | - | - |
| Depreciation and amortization | 112,900 | 112,500 | 112,100 | 217,400 |
| Loss on extinguishment of debt | - | 0 | -5,100 | - |
| Asset write off related to restructuring, integration and other charges | - | 0 | 800 | 151,400 |
| Stock-based compensation expense | 10,700 | 10,800 | 10,700 | 24,400 |
| Asset write off related to tax assessment refund | - | 0 | - | - |
| Change in deferred tax assets and liabilities | -1,800 | 7,800 | -1,000 | -500 |
| Other non-cash, net | 4,900 | 2,400 | -15,800 | 14,300 |
| Accounts receivable | -54,000 | 28,800 | 113,400 | -24,700 |
| Inventories | 72,600 | 6,600 | 39,100 | 102,600 |
| Prepaid expenses and other current and non-current assets | -18,700 | 18,500 | 7,600 | 8,500 |
| Accounts payable | -27,700 | 55,900 | 7,600 | -23,500 |
| Accrued payroll and related expenses | 15,700 | 15,800 | 20,000 | -34,900 |
| Income tax receivable and payable | 13,000 | 10,500 | -26,300 | 57,500 |
| Other current and non-current liabilities | -69,000 | 100,800 | 24,000 | -32,800 |
| Net cash (used for) provided by operating activities | -33,000 | 131,900 | -45,500 | 18,800 |
| Purchases of marketable securities | - | 0 | 0 | 0 |
| Proceeds from sale of marketable securities | - | 0 | 0 | 0 |
| Proceeds from held for sale asset, net of costs to sell | - | 0 | - | - |
| Proceeds from government assistance allocated to fixed assets | - | 0 | 0 | 6,500 |
| Loan to lex diagnostics | - | 4,300 | 4,700 | 2,000 |
| Acquisitions of property, plant, equipment, investments and intangibles | 34,000 | 45,300 | 49,200 | 93,700 |
| Net cash used for investing activities | -34,000 | -49,600 | -53,900 | -89,200 |
| Proceeds from issuance of common stock | 1,800 | 100 | 2,900 | 3,100 |
| Short-term borrowings, net | -1,700 | -2,300 | 3,400 | 1,900 |
| Revolving credit facility, net | 50,000 | -20,000 | -290,000 | 192,000 |
| Proceeds from long-term borrowings | 12,600 | 13,100 | 2,546,200 | - |
| Payments on long-term borrowings | 22,400 | 1,600 | 2,215,600 | 72,000 |
| Payments on finance lease obligation | 1,600 | - | - | - |
| Payments of tax withholdings related to vesting of stock-based awards | 1,100 | 400 | 900 | 4,100 |
| Repurchases of common stock | - | 0 | - | - |
| Principal payments of deferred consideration | - | 0 | - | - |
| Net cash provided by financing activities | 37,600 | -11,100 | 46,000 | 120,900 |
| Effect of exchange rates on cash | 0 | 500 | -200 | 2,700 |
| Net (decrease) increase in cash, cash equivalents and restricted cash | -29,400 | 71,700 | -53,600 | 53,200 |
| Cash, cash equivalents and restricted cash at beginning of period | 169,800 | 98,100 | 98,500 | - |
| Cash, cash equivalents and restricted cash at end of period | 140,400 | 169,800 | 98,100 | - |